Search Within

Dean Bajorin

  1. "Survivorship Research"
Formats
  1. Journal Article (138)
  2. Meeting Abstract (79)
  3. Book Section (6)
  4. Conference Paper (4)
  5. Correspondence (3)
Groups
  1. Department of Medicine (230)
  2. Genitourinary Oncology Service (230)
  3. Solid Tumor Oncology Division (230)
  4. Survivorship Research (230)
  5. Surgery (147)
  6. Urology (140)

More Groups

People
  1. George Bosl (146)
  2. Robert Motzer (116)
  3. Joel Sheinfeld (76)
  4. Jonathan Rosenberg (48)
  5. Darren Feldman (47)
  6. Bernard Bochner (46)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (11)
  5. 2021 (11)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Cancer (14)
  3. Journal of Urology (14)
  4. Cancer Research (10)
  5. Urology (10)
  6. Seminars in Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (112)
  2. Elsevier Science, Inc. (27)
  3. American Association for Cancer Research (18)
  4. Elsevier Inc. (16)
  5. Wiley Blackwell (16)
  6. Springer (7)

More Publishers

Results (230)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients
    Journal Article

    Motzer, R. J.; Mazumdar, M.; Sheinfeld, J.; Bajorin, D. F.; Macapinlac, H. A.; Bains, M.; Reich, L.; Flombaum, C.; Mariani, T.; Tong, W. P.; more...
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors
    Journal Article

    Vuky, J.; McCaffrey, J.; Ginsberg, M.; Mariani, T.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2000)

    Fulltext@MSK | Save
  • Bleomycin in nonseminomatous germ-cell tumors: Cure rate versus morbidity - In reply
    Journal Article

    Bajorin, D. F.; Bosl, G. J.
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Medical and surgical management of pulmonary metastases from germ cell tumors
    Journal Article

    Xiao, H.; Liu, D.; Bajorin, D. F.; Burt, M.; Bosl, G. W.
    Chest Surgery Clinics of North America (1998)

    Fulltext@MSK | Save
  • Metastatic germ cell tumors: Modeling for response to chemotherapy
    Journal Article

    Bajorin, D. F.; Mazumdar, M.; Meyers, M.; Motzer, R. J.; Vlamis, V.; Lin, P.; Bosl, G. J.
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Testicular germ cell tumors: Immunohistochemistry analysis of p53, Ki-67, EGFr, and apoptosis
    Meeting Abstract

    Xiao, H.; Bajorin, D. F.; Mazumdar, M.; Spicer, J.; Chaganti, R.; Bosl, G. J.; Reuter, V. E.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Cancer of the testis
    Book Section

    Bosl, G. J.; Sheinfeld, J.; Bajorin, D. F.; Motzer, R. J.
    In DeVita V. T. Jr; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 5th ed (1997)

    Fulltext@MSK | Save
  • Residual masses after chemotherapy for metastatic testicular cancer: The clinical implications of the association between retroperitoneal and pulmonary histology
    Journal Article

    Steyerberg, E. W.; Donohue, J. P.; Gerl, A.; Toner, G. C.; Koops, H. S.; Fossa, S. D.; Keizer, H. J.; for the Re-Analysis of Histology in Testicular Cancer (ReHiT) Study Group
    Journal of Urology (1997)

    Fulltext@MSK | Save
  • Surgery for a post-chemotherapy residual mass in seminoma
    Journal Article

    Herr, H. W.; Sheinfeld, J.; Puc, H. S.; Heelan, R.; Bajorin, D. F.; Mencel, P.; Bosl, G. J.; Motzer, R. J.
    Journal of Urology (1997)

    Fulltext@MSK | Save
  • International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
    Journal Article

    International Germ Cell Cancer Collaborative Group
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save